De Novo Drug Design with Joint Transformers
De novo drug design requires simultaneously generating novel molecules outside of training data and predicting their target properties, making it a hard task for generative models. To address this, we propose Joint Transformer that combines a Transformer decoder, Transformer encoder, and a predictor in a joint generative model with shared weights. We formulate a probabilistic black-box optimization algorithm that employs Joint Transformer to generate novel molecules with improved target properties and outperforms other SMILES-based optimization methods in de novo drug design.
Code (0)
등록된 구현이 없습니다.
Tasks
DecoderDrug DesignMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
NovoMol: Recurrent Neural Network for Orally Bioavailable Drug Design and Validation on PDGFRα Receptor
Longer timelines and lower success rates of drug candidates limit the productivity of clinical trials in the pharmaceutical industry. Promising de novo drug design techniques help solve this by exploring a broader chemic…
Drug DesignA Survey of Generative AI for de novo Drug Design: New Frontiers in Molecule and Protein Generation
Artificial intelligence (AI)-driven methods can vastly improve the historically costly drug design process, with various generative models already in widespread use. Generative models for de novo drug design, in particul…
Drug DesignMulti-domain Distribution Learning for De Novo Drug Design
We introduce DrugFlow, a generative model for structure-based drug design that integrates continuous flow matching with discrete Markov bridges, demonstrating state-of-the-art performance in learning chemical, geometric,…
Structure-aware generation of drug-like molecules
Structure-based drug design involves finding ligand molecules that exhibit structural and chemical complementarity to protein pockets. Deep generative methods have shown promise in proposing novel molecules from scratch …
Drug DesignDeep Lead Optimization: Leveraging Generative AI for Structural Modification
The idea of using deep-learning-based molecular generation to accelerate discovery of drug candidates has attracted extraordinary attention, and many deep generative models have been developed for automated drug design, …
Drug Design